Acetylsalicylic acid, 99%, Thermo Scientific Chemicals
Acetylsalicylic acid, 99%, Thermo Scientific Chemicals
Acetylsalicylic acid, 99%, Thermo Scientific Chemicals
Acetylsalicylic acid, 99%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Acetylsalicylic acid, 99%, Thermo Scientific Chemicals

Acetylsalicylic acid, aspirin, CAS# 50-78-2, is a non-steroidal anti-inflammatory that is used widely as an analgesic and antipyretic.
Have Questions?
Catalog NumberQuantityPackaging
15818050050 gPlastic bottle
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number 158180500
Price (EUR)
-
Quantity:
50 g
Packaging:
Plastic bottle
Request bulk or custom format
Chemical Identifiers
CAS50-78-2
IUPAC Name2-(acetyloxy)benzoic acid
Molecular FormulaC9H8O4
InChI KeyBSYNRYMUTXBXSQ-UHFFFAOYSA-N
SMILESCC(=O)OC1=CC=CC=C1C(O)=O
View more
SpecificationsSpecification SheetSpecification Sheet
Sulfated ash=<0.1 %
Melting point133°C to 139°C
Titration with NaOH98.5 to 101.5 % (On dried substance)
Loss on drying=<0.5 % (1 g) (vacuum, over P2O5, room temp)
Infrared spectrumConforms
View more
Ask our AI about this Product
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General description
• Acetylsalicylic acid is a common non-steroidal anti-inflammatory (NSAID) and
• Acetylsalicylic acid works by inhibiting cyclooxygenases, reducing prostaglandin production and the release of pyrogens


Applications
• Acetylsalicylic acid is useful for research on fever, postoperative pain, blood clots, and inflammation
• Acetylsalicylic acid may also be used in the study of cancer prevention
• Intended for research use only

Literature references

Levine, G.N.; Bates, E.R.; Bittl, J.A.; Brindis, R.G.; Fihn, S.D.; Fleisher, L.A.; Granger, C.B.; Lange, R.A.; Mack, M.J.; Mauri, L.; Mehran, R.; Mukherjee, D.; Newby, L.K.; O'Gara, P.T.; Sabatine, M.S.; Smith, P.K.; Smith, S.C. Jr. 2016, ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68(10), 1082-115.

Hoffman, M.K.; Goudar, S.S.; Kodkany, B.S.; Metgud, M.; Somannavar, M.; Okitawutshu, J.; Lokangaka, A.; Tshefu, A.; Bose, C.L.; Mwapule, A.; Mwenechanya, M.; Chomba, E.; Carlo, W.A.; Chicuy, J.; Figueroa, L.; Garces, A.; Krebs, N.F.; Jessani, S.; Zehra F.; Saleem, S.; Goldenberg, R.L.; Kurhe, K.; Das, P.; Patel, A.; Hibberd, P.L.; Achieng, E.; Nyongesa, P.; Esamai, F.; Liechty, E.A.; Goco, N.; Hemingway-Foday, J.; Moore, J.; Nolen, T.L.; McClure, E.M.; Koso-Thomas, M.; Miodovnik, M.; Silver, R.; Derman, R.J. ASPIRIN Study Group. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020, 25, 395(10220), 285-293.

RUO – Research Use Only

General References:

  1. Levine, G.N.; Bates, E.R.; Bittl, J.A.; Brindis, R.G.; Fihn, S.D.; Fleisher, L.A.; Granger, C.B.; Lange, R.A.; Mack, M.J.; Mauri, L.; Mehran, R.; Mukherjee, D.; Newby, L.K.; O'Gara, P.T.; Sabatine, M.S.; Smith, P.K.; Smith, S.C. Jr. 2016, ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68(10), 1082-115.
  2. Hoffman, M.K.; Goudar, S.S.; Kodkany, B.S.; Metgud, M.; Somannavar, M.; Okitawutshu, J.; Lokangaka, A.; Tshefu, A.; Bose, C.L.; Mwapule, A.; Mwenechanya, M.; Chomba, E.; Carlo, W.A.; Chicuy, J.; Figueroa, L.; Garces, A.; Krebs, N.F.; Jessani, S.; Zehra F.; Saleem, S.; Goldenberg, R.L.; Kurhe, K.; Das, P.; Patel, A.; Hibberd, P.L.; Achieng, E.; Nyongesa, P.; Esamai, F.; Liechty, E.A.; Goco, N.; Hemingway-Foday, J.; Moore, J.; Nolen, T.L.; McClure, E.M.; Koso-Thomas, M.; Miodovnik, M.; Silver, R.; Derman, R.J. ASPIRIN Study Group. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020, 25, 395(10220), 285-293.
Have questions about this product? Ask our AI assisted search.
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our Privacy Notice.

Documents & Downloads

Certificates

Safety Data Sheets

Safety and Handling

Classification of the substance or mixture
CLP classification - Regulation(EC) No 1272/2008
Acute oral toxicity
Category 4
Label Elements
Signal Word

Warning

Hazard Statements

H302 - Harmful if swallowed

Precautionary Statements

P264 - Wash face, hands and any exposed skin thoroughly after handling

P301 + P330 + P331 - IF SWALLOWED: rinse mouth. Do NOT induce vomiting

P312 - Call a POISON CENTER or doctor if you feel unwell

Share catalog number, name or link